Comparison of actual and stated concentrations of pharmaceuticals manufactured in Mexico

Clinical Therapeutics

Volumn 27, Issue 5, 2005, Pages 609-615

  Schwertner, Harvey A ^a   Storrow, Alan B ^b  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Drugs; Expiration dates; Mexico; Percent of labeled amount; Pharmaceuticals; Pharmacies; Quality; USP standards

Indexed keywords

CARBAMAZEPINE; DIAZEPAM; DIGOXIN; GENERIC DRUG; HYDANTOIN; MAPAP; NON PRESCRIPTION DRUG; PARACETAMOL; PHENYTOIN; PROMPT PHENYTOIN SODIUM;

ARTICLE; COLOR; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); DRUG LABELING; DRUG MANUFACTURE; DRUG PACKAGING; EXPIRATION DATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MEXICO; PHARMACIST; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; SAMPLE; STANDARD; UNITED STATES;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG INDUSTRY; DRUG PACKAGING; MEXICO; PHARMACEUTICAL PREPARATIONS; QUALITY CONTROL;

EID: 20644446491     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2005.05.007     Document Type: Article

References (10)

1. Casner PR, and Guerra LG Purchasing prescription medication in Mexico without a prescription. The experience at the border West J Med 156 1992 512 516
2. Warner DC Health issues at the US-Mexican border JAMA 265 1991 242 247
3. Tabet SR, and Wiese WH Medications obtained in Mexico by patients in southern New Mexico South Med J 83 1990 271 273
4. Cornbleet J Mexicol It's Marlboro country [letter to the editor] JAMA 267 1992 3286
5. Frankel HH An offshore pharmacy-a bargain or a danger? West J Med 159 1993 94 95
6. Meadows M Imported drugs raise safety concerns FDA Consum 36 2002 18 23
7. McKeithan EK, and Shepherd MD Pharmaceutical products declared by US residents on returning to the United States from Mexico Clin Ther 18 1996 1242 1251
8. The United States Pharmacopoeia The National Formulary: USP 23 NF 18 1994 United States Pharmacopoeial Convention, Inc, Taunton, Mass
9. Dept of Health, Education, and Welfare, US Food and Drug Administration Nonclinical Laboratory Studies, Good Laboratory Practice Regulations Fed Reg 43 1978 1 66
10. Moyer TP, and Oliver LK Supporting pharmaceutical studies for FDA submissions: Diversifying the drug monitoring laboratory Clin Chem 44 1998 433 436